Medication info
Rovataryn Tablet 10 mg (Rosuvastatin Calcium)

Rovataryn Tablet 10 mg (Rosuvastatin Calcium)

Prescription medicationTablet
Ingredient · strength
Rosuvastatin Calcium›10.4mg / 1 tablet
Manufacturer / importer
Independent BioPharmaceutical Co., Ltd.
Appearance
Pink round film-coated tablets
Packaging
30 tablets (15 tablets/PTP x 2 pieces)
Approval status
Active

MFDS item code 201905929 · Approved 2019.08.22 · Insurance code 057700310

Summary

Main use
Treatment of dyslipidemia, inhibition of the progression of atherosclerosis, and prevention of cardiovascular disease
Who uses it
Adults · Children
Adult dosage
1. Primary hypercholesterolemia (type IIa, including heterozygous familial hypercholesterolemia), mixed dyslipidemia (type IIb), primary dysbetalipoproteinemia (type III), and homozygous familial hypercholesterolemia Patients should follow a standard cholesterol-lowering diet before and during treatment with this drug and continue it throughout the treatment period. This drug may be taken at any time of day, with or without food. The initial dose is 5 milligrams once daily. If a greater reduction in LDL cholesterol is needed, the dose may be adjusted to the maintenance dose. The maintenance dose is 10 milligrams once daily, which is sufficient to control the condition in most patients. The maintenance dose should be appropriately adjusted at intervals of 4 weeks or more according to the LDL cholesterol level, treatment goal, and patient response, and may be increased up to a maximum of 20 milligrams once daily. 3. Elderly patients: No dose adjustment is necessary. 4. Patients with renal impairment: No dose adjustment is necessary in patients with mild or moderate renal impairment. This drug should not be administered to patients with severe renal impairment. Particular caution is required when administering this drug at a dose of 20mg to patients with moderate renal impairment. 5. Patients with hepatic impairment: Systemic exposure to rosuvastatin was not increased in patients with a Child-Pugh score of 7 or less, but was increased in patients with a Child-Pugh score of 8 or 9. Renal function tests should be considered in these patients. There is no experience with administration to patients with a Child-Pugh score greater than 9. This drug should not be administered to patients with active liver disease. 6. Race: Because systemic exposure to this drug is increased in Asian patients, the recommended initial dose is 5 milligrams. Administration of the 40-milligram dose is contraindicated. 7. Patients predisposed to myopathy: The recommended initial dose for patients predisposed to myopathy is 5 milligrams. Administration of the 40-milligram dose is contraindicated in some of these patients.
Children's dosage
Age 10 to 17 years: The usual dose range is 5 milligrams to 20 milligrams once daily. (There are no clinical data on doses higher than 20 milligrams in pediatric patients.) The dose should be adjusted individually according to the recommended treatment goal for each patient. The dose should be adjusted at intervals of 4 weeks or more. Under 10 years: Safety and efficacy in children have not been established.

Ingredients

Manufacturer
Independent BioPharmaceutical Co., Ltd.

Efficacy & effects

Treatment of dyslipidemia, inhibition of the progression of atherosclerosis, and prevention of cardiovascular disease

  • Primary hypercholesterolemia
  • mixed dyslipidemia
  • homozygous familial hypercholesterolemia
  • hypercholesterolemia
  • heterozygous familial hypercholesterolemia
  • primary dysbetalipoproteinemia
  • risk of stroke
  • risk of myocardial infarction
View approved original text

This drug is used as an adjunct to diet in patients with primary hypercholesterolemia and mixed dyslipidemia when dietary and exercise controls are insufficient. It is also used as an adjunct with other lipid-lowering therapies in patients with homozygous familial hypercholesterolemia. This drug helps lower total cholesterol and LDL cholesterol levels, thereby slowing the progression of atherosclerosis. In particular, it is used as an adjunct to diet in pediatric patients with heterozygous familial hypercholesterolemia aged 10 to 17 years, effectively managing cholesterol levels in high-risk patients. Additionally, it is used as an adjunct to diet in primary dysbetalipoproteinemia. With effects in reducing cardiovascular disease risk, it helps lower the risk of stroke, myocardial infarction, and arterial revascularization in high-risk patients over middle age.

Dosage and Administration

Adult dosage

1. Primary hypercholesterolemia (type IIa, including heterozygous familial hypercholesterolemia), mixed dyslipidemia (type IIb), primary dysbetalipoproteinemia (type III), and homozygous familial hypercholesterolemia Patients should follow a standard cholesterol-lowering diet before and during treatment with this drug and continue it throughout the treatment period. This drug may be taken at any time of day, with or without food. The initial dose is 5 milligrams once daily. If a greater reduction in LDL cholesterol is needed, the dose may be adjusted to the maintenance dose. The maintenance dose is 10 milligrams once daily, which is sufficient to control the condition in most patients. The maintenance dose should be appropriately adjusted at intervals of 4 weeks or more according to the LDL cholesterol level, treatment goal, and patient response, and may be increased up to a maximum of 20 milligrams once daily. 3. Elderly patients: No dose adjustment is necessary. 4. Patients with renal impairment: No dose adjustment is necessary in patients with mild or moderate renal impairment. This drug should not be administered to patients with severe renal impairment. Particular caution is required when administering this drug at a dose of 20mg to patients with moderate renal impairment. 5. Patients with hepatic impairment: Systemic exposure to rosuvastatin was not increased in patients with a Child-Pugh score of 7 or less, but was increased in patients with a Child-Pugh score of 8 or 9. Renal function tests should be considered in these patients. There is no experience with administration to patients with a Child-Pugh score greater than 9. This drug should not be administered to patients with active liver disease. 6. Race: Because systemic exposure to this drug is increased in Asian patients, the recommended initial dose is 5 milligrams. Administration of the 40-milligram dose is contraindicated. 7. Patients predisposed to myopathy: The recommended initial dose for patients predisposed to myopathy is 5 milligrams. Administration of the 40-milligram dose is contraindicated in some of these patients.

Children's dosage

Age 10 to 17 years: The usual dose range is 5 milligrams to 20 milligrams once daily. (There are no clinical data on doses higher than 20 milligrams in pediatric patients.) The dose should be adjusted individually according to the recommended treatment goal for each patient. The dose should be adjusted at intervals of 4 weeks or more. Under 10 years: Safety and efficacy in children have not been established.

Precautions

This drug may not be suitable for certain patients. For example, patients with allergies to this drug's components, severe liver dysfunction, muscle diseases, and severe renal impairment should avoid it. Moreover, pregnant or nursing women should not use this drug, and women of childbearing potential should take appropriate contraceptive measures to reduce the possibility of pregnancy. This drug may cause muscle-related side effects, so immediate medical consultation is required if symptoms like muscle pain or weakness appear. Special caution is advised for patients with kidney or thyroid issues, or a history of muscle diseases. Regular liver function tests and muscle enzyme tests should be performed, and patients with a history of liver disease or high alcohol consumption should be prescribed this drug cautiously. Because this drug’s blood levels may increase and the risk of side effects may rise when taken with certain medications, inform medical personnel of any concurrent medications. Pregnant or nursing women should not take this drug, and women planning pregnancy must consult a doctor. In case of an overdose, there is no specific antidote, so immediate hospital treatment is necessary, and liver function and muscle enzyme levels should be monitored. While taking this drug, dizziness or headaches may occur, so caution is needed when driving or operating machinery. Finally, this drug contains lactose, so patients with lactose intolerance should consult before taking it.

Side effects

Angioedema, hypersensitivity reactions, diabetes, headache, dizziness, constipation, nausea, abdominal pain, pancreatitis, pruritus, rash, urticaria, myalgia, myopathy, rhabdomyolysis, weakness, polyneuropathy, amnesia, peripheral neuropathy, myasthenia gravis, cough, dyspnea, diarrhea, ocular myasthenia, thrombocytopenia, jaundice, hepatitis, increased transaminases, Stevens-Johnson syndrome, eosinophilia, drug reaction with eosinophilia and systemic symptoms (DRESS), drug-induced erythema multiforme, lupus-like syndrome, muscle rupture, arthralgia, immune-mediated necrotizing myopathy, hematuria, edema, depression, sleep disorders, interstitial lung disease, sexual dysfunction, gynecomastia, fatal and non-fatal liver failure, cognitive impairment, increased ALT, chest pain, muscle cramps, gout, erectile dysfunction, increased AST, numbness, sensory disturbances, chest discomfort, loss of appetite, abdominal distension, syncope, generalized pain

Not everyone experiences these, and they can vary from person to person.

Storage

Store this drug in a tightly sealed container to protect it from exposure to air or moisture, and keep it at a temperature between 1°C and 30°C. Proper storage will help maintain the drug's effectiveness and prevent degradation.

Appearance and packaging

Appearance

Pink round film-coated tablets

Package unit

30 tablets (15 tablets/PTP x 2 pieces)

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.